Economic Burden of Skin Diseases among Hospitalized Patients in North of Iran
نویسندگان
1 Skin Research Center, Department of Dermatology, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
2 Social Determinants of Health Research Center Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran
3 Skin Research Center, Department of Dermatology, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
4 Skin Research Center, Department of Dermatology, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
doi
10.22034/ircmj.2024.469542.1331چکیده
Background and Objectives: Skin diseases are alarmingly prevalent and significantly burden public health. This study aimed to investigate the economic burden arising from skin diseases among patients in the dermatology department. Methods: This cross-sectional study was conducted on 362 patients with skin diseases referred to Razi Educational and Medical Center, Guilan University of Medical Sciences, Rasht, Iran. Data of patients was recorded, and the economic burden, hospitalization cost, and disability-adjusted life year (DALY) were calculated based on the visual analog scale (VAS), time trade-off method (TTO), and TTO-10 years. Results: The mean hospitalization days was 25.56±1.81 and pemphigus was the most prevalent skin disease (20.71%), followed by dermatitis and psoriasis (11.32% and 11.04%, respectively). The mean total hospitalization cost was 600,025±400,023 Rials, resulting in a total cost of absence from work of 80,404,000±305,000 Rials. The analysis of DALY and economic burden revealed that the highest costs were associated with the TTO method for both DALY and hospitalization. The length of stay showed a significant association with hospital cost, economic burden, and DALY. Conclusion: Economic burden of skin diseases in Guilan province, Iran, was influenced by hospital stay length and disease severity. While it might not be high compared to the global average, the study highlights significant costs associated with skin diseases.